MUSNI, THEO ROI N.

OB WARD | NCP & DRUG STUDY

BSN 4B2B APRIL 27-29, 2023

For patient X
ASSESSMENT DIAGNOSIS PLANNING INTERVENTION RATIONALE EVALUATION

SUBJECTIVE: SHORT TERM SHORT TERM GOAL

Acute Pain GOAL: INDEPENDENT MET:
- Patient reports pain related to surgical
at surgical incision incision as After 30 minutes of - Educate the patient -Educating the patient After 30 minutes of
site and rates it as evidence by pain nursing intervention on about pain nursing intervention
6/10 on pain scale. scale of 6/10 the client will be able non-pharmacological management the client was able to:
related to to: pain management techniques and the
- Patient is guarding postoperative strategies, such as importance of - Verbalize
her abdomen and cesarean section. - Verbalize relaxation techniques reporting changes in nonpharmacol
grimacing when nonpharmacol and positioning. pain can help the ogic methods
moving. ogic methods patient take an active that provide
that provide role in their recovery relief.
- Vital signs: relief. and ensure
BP: 140/80 appropriate pain - Demonstrate
RR: 22 - Demonstrate management. use of
use of relaxation
relaxation -Encourage the -Relaxation techniques.
techniques. patient to move and techniques help the
perform deep patient manage pain - Experience
- Experience breathing exercises to by reducing stress decreased
decreased promote pain relief and anxiety, which pain as
pain as and prevent can exacerbate pain. evidenced by
evidenced by complications. a pain scale of
a pain scale of 3/10
3/10 -Provide comfort
measures, such as ice - Show a normal
- Show a normal packs, heating pads, vital signs
vital signs and massage.
LONG TERM GOAL
LONG TERM GOAL: -Monitor vital signs, PARTIALLY MET:
respiratory rate, and
After 5 days of oxygen saturation. After 2 days of
nursing intervention nursing intervention
the client will be able -Reposition the -Repositioning the the client was able to:
 to: patient frequently and patient frequently can
assist with movement help prevent pressure - Experience
- Experience as needed. ulcers and assist with reduce pain.
absence of healing. Movement
pain. also helps prevent - Demonstrate
blood clots and Non-pharmaco
- Demonstrate promotes circulation, logical pain
Non-pharmaco which can help reduce management
logical pain pain and discomfort. techniques
management
techniques COLLABORATIVE

-Collaborate with the

healthcare team to
adjust the pain
management plan as
necessary.

DEPENDENT
- Administer pain -Analgesics help
medication as ordered relieve pain and
by the physician, discomfort, making it
including non-opioid easier for the patient
analgesics (e.g., to move and breathe.
acetaminophen, Pain management is
mefenamic acid) and crucial to the patient's
opioids (e.g., recovery and overall
morphine, fentanyl) as well-being.
appropriate.

ASSESSMENT DIAGNOSIS PLANNING INTERVENTION RATIONALE EVALUATION

SUBJECTIVE: SHORT TERM SHORT TERM GOAL

Risk for GOAL: -Provide education to -Education about MET:
- G3 P2 (20131) Unintended the client about various contraceptive
- “Hindi po kami Pregnancy After 30 minutes of various contraceptive methods and their After 30 minutes of
gumagamit ng related to lack of nursing intervention methods, including benefits and risks can nursing intervention
contraceptive”as contraception use the client will be able hormonal and help the client make the client was able to:
verbalized by the and history of to: non-hormonal options, informed decisions
 client previous and their about contraception - Verbalize
- “Nakunan po ako abortions. - Verbalize effectiveness. use. understanding
noong understanding related to
pangalawang related to -Discuss the benefits various
pagbubuntis ko, various and risks of each contraceptive
mga 2 months na contraceptive contraceptive method methods
yung baby sa methods with the client,
sinapupunan ko” as including any potential - Demonstrate
verbalized by the - Demonstrate side effects or understanding
client understanding interactions with other related to
related to medications. benefits and
benefits and risks of each
risks of each contraceptive
contraceptive methods
methods -Encourage the client -Encouraging the
to discuss their client to discuss their LONG TERM GOAL
LONG TERM GOAL: concerns and beliefs concerns and beliefs MET:
about contraception about contraception
After 2 days of with their healthcare with their healthcare After 2 days of
nursing intervention provider and/or provider and/or nursing intervention
the client will be able partner. partner can facilitate the client will be able
to: communication and to:
improve adherence to
- Discuss their contraception use. - Discuss their
concerns and concerns and
beliefs about -Assist the client in -Assisting the client in beliefs about
contraception obtaining affordable obtaining affordable contraception
and appropriate and appropriate
- Verbalize contraception contraception - Verbalize
appropriate methods, such as methods can remove appropriate
contraceptive condoms, oral barriers to contraceptive
method contraceptives, or contraception use and method
suitable for intrauterine devices reduce the risk of suitable for
them. (IUDs). unintended them.
pregnancy.
- Demonstrate -Provide education to - Demonstrate
understanding the client about the -Education about the understanding
about risks of risks of STIs and risks of STIs and about risks of
STI and ways ways to prevent ways to prevent STI and ways
to prevent transmission, transmission can to prevent
possible including abstinence, reduce the risk of possible
 transmission. condom use, and STIs and potential transmission.
regular STI testing. complications.

-Refer the client to -Referral to

appropriate appropriate
community resources, community resources
such as family for emotional and
planning clinics or social support can
support groups, for provide the client with
emotional and social additional support and
support. resources to help
them manage their
reproductive health.

For Patient Y
ASSESSMENT DIAGNOSIS PLANNING INTERVENTION RATIONALE EVALUATION

OBJECTIVE: SHORT TERM -Assess the patient's -Regular assessment SHORT TERM GOAL
Risk for Infection GOAL: incision site and of the incision site and MET:
Lymphocytes: 42 (20 - related to recent surrounding skin at surrounding skin is
40%) total After 30 minutes of least once a shift for necessary to detect After 30 minutes of
hysterectomy. nursing intervention signs of infection, any signs of infection nursing intervention
Decreased hematocrit and the client will be able such as redness, early and prevent the client was able to:
hemoglobin levels, to: swelling, warmth, and complications.
indicating possible blood drainage. - Verbalized
loss and decreased ability - Verbalized understanding
to fight infection with a lab understanding -Encourage the -Proper nutrition and related to
value of related to patient to maintain a hydration are proper hand
proper hand healthy diet and drink essential for wound hygiene and
Hematocrit: 0.34 (0.36 - hygiene and plenty of fluids to healing and immune incision care to
0.56) incision care to support healing and system function. prevent
prevent prevent infection. infection.
Hemoglobin: 112 (120-150 infection.
g/l) -Teach the patient and -Education on hand - Verbalized
- Verbalized their family about hygiene and incision understanding
understanding proper hand hygiene care can help prevent related to
related to and incision care to the spread of healthy eating
healthy eating prevent infection. infection. habits and rest
habits and rest to promote
 to promote -Administer -Prophylactic healing
healing prophylactic antibiotics are -
antibiotics as ordered commonly used to
LONG TERM GOAL: by the physician to reduce the risk of LONG TERM GOAL
reduce the risk of infection after surgery. MET:
After 5 days of infection.
nursing intervention After 2 days of
the client will be able -Encourage the -Rest and avoiding nursing intervention
to: patient to rest and overexertion can the client was able to:
avoid overexertion to promote healing and
- Demonstrate promote healing and prevent complications. - Demonstrate
proper hand prevent infection. proper hand
hygiene and hygiene and
incision care to -Monitor the patient's -Regular monitoring of incision care to
prevent vital signs and vital signs and prevent
infection. laboratory values laboratory values can infection.
regularly to detect any detect any signs of
- Demonstrate signs of infection. infection early and - Demonstrate
healthy eating prompt appropriate healthy eating
habits and rest interventions. habits and rest
to promote to promote
healing -Collaborate with -Collaboration with healing
other healthcare team other healthcare team
- Continuous members to ensure members can ensure - Continuous
healing with appropriate and timely that the patient healing with
absence of interventions if receives appropriate absence of
infection infection is detected. care and interventions infection
if an infection is
detected.

DRUG NAME INDICATION, MECHANISM OF SIDE CONTRAINDICATIO NURSING

DOSAGES, ACTION EFFECTS/ADVERSE NS RESPONSIBILITIES
FREQUENCY, REACTION
ROUTE

>Mild to moderate -Mefenamic acid Significant: Na and -Hypersensitivity to -Should be taken with
GENERIC NAME: pain, Osteoarthritis, works by inhibiting fluid retention, mefenamic acid; food
 Rheumatoid arthritis the activity of diarrhoea, new-onset history of
- Mefenamic Acid cyclooxygenase or worsening of hypersensitivity -Assessing the
Oral (COX) enzymes, hypertension, reaction (e.g. asthma, patient's medical
which are responsible hyperkalaemia; renal rhinitis, angioedema, history to ensure that
Adult: 500 mg tid. for producing papillary necrosis and urticaria) to aspirin or there are no
Alternatively, initiate at prostaglandins that other renal injury other NSAIDs. contraindications or
500 mg, followed by cause pain, (prolonged use); may Inflammatory bowel risk factors that could
250 mg 6 hourly as inflammation, and impair female fertility disease, history of impact the safe use of
necessary, usually not fever. By inhibiting (prolonged use); gastrointestinal mefenamic acid.
more than 1 week. COX enzymes, aseptic meningitis bleeding or
Use the lowest mefenamic acid (particularly in patients perforation related to -Checking the
effective dose for the reduces the with autoimmune previous NSAID patient's vital signs,
shortest possible production of these disorders), decreased therapy, active including blood
duration. prostaglandins, platelet adhesion and gastrointestinal pressure, heart rate,
leading to a reduction aggregation, anaemia. ulceration or bleeding, and temperature, to
Child: As oral susp: in pain and Rarely, potentially history of recurrent monitor for any
>6 months to <2 years inflammation. severe blood peptic ulcer disease changes or adverse
25 mg/kg daily in dyscrasias (e.g. or haemorrhage (≥2 effects.
divided doses or 50 agranulocytosis, distinct episodes of
mg 1-3 times daily; thrombocytopenia, proven ulceration or -Administering the
2-<5 years 100 mg aplastic anaemia). bleeding), severe correct dose of
1-3 times daily; 5-<9 heart failure. Use in mefenamic acid as
years 150 mg 1-3 Cardiac disorders: the setting of CABG prescribed by the
times daily; 9-<12 Cardiac failure, surgery. Severe renal healthcare provider
years 200 mg 1-3 palpitations. and hepatic and ensuring that the
times daily. As tab or impairment. medication is given at
cap: ≥12 years Same Ear and labyrinth Pregnancy (3rd the appropriate time
as adult dose. Use the disorders: Ear pain, trimester). intervals.
lowest effective dose vertigo, tinnitus.
for the shortest -Monitoring the patient
possible duration. Eye disorders: for any adverse
Max treatment Blurred vision, reactions to the
duration: 7 days reversible loss of medication, such as
(except in the colour vision, eye gastrointestinal
treatment of systemic irritation. bleeding, allergic
onset juvenile chronic reactions, or renal
arthritis). Treatment Gastrointestinal dysfunction.
recommendations disorders: Nausea,
may vary among vomiting, dyspepsia, -Providing patient
countries and constipation, education about the
individual products abdominal pain, proper use of
(refer to specific melaena, mefenamic acid,
product guidelines). haematemesis, including the potential
Elderly: Use the ulcerative stomatitis, side effects,
lowest effective dose exacerbation of precautions to take,
for the shortest Crohn's disease and and when to seek
possible duration. colitis, pancreatitis, medical attention.
steatorrhoea,
>Menorrhagia,Primary enterocolitis. -Documenting the
dysmenorrhoea administration of
General disorders mefenamic acid in the
Oral and administration patient's medical
site conditions: record, including the
Adult: 500 mg tid. Fatigue, malaise, dose, time, route of
Alternatively, initiate at pyrexia. administration, and
500 mg, followed by any adverse reactions
250 mg 6 hourly. Start Investigations: or interventions.
treatment at the onset Elevated LFTs.
of excessive bleeding -Communicating with
or menstrual pain. Metabolism and the healthcare
Use the lowest nutrition disorders: provider if there are
effective dose for the Glucose intolerance (in any concerns about
shortest possible diabetic patients), the patient's response
duration. hyponatraemia, to mefenamic acid or
anorexia. if any unexpected
>Fever adverse reactions
Nervous system occur.
Oral disorders: Headache,
dizziness, drowsiness,
Child: As oral susp: paraesthesia,
>6 months 25 mg/kg convulsions.
daily in divided doses. Psychiatric
Use the lowest disorders:
effective dose for the Depression, confusion,
shortest possible hallucinations,
duration. Max nervousness,
treatment duration: 7 insomnia.
days. Treatment
recommendations Renal and urinary
may vary among disorders: Dysuria,
countries and haematuria, cystitis.
individual products
(refer to specific Respiratory, thoracic
product guidelines). and mediastinal
disorders: Dyspnoea.

Skin and
subcutaneous tissue
disorders: Rash,
pruritus, urticaria,
photosensitivity
reaction, alopecia,
perspiration.

Vascular disorders:
Hypotension.

Potentially Fatal: CV
thrombotic events
(including MI and
stroke),
gastrointestinal
inflammation,
bleeding, ulceration, or
perforation;
bronchospasm (in
patients with
aspirin-sensitive
asthma). Rarely,
severe
anaphylactic-like
reactions, drug
reaction with
eosinophilia and
systemic symptoms
(DRESS) or multiorgan
hypersensitivity
reactions, exfoliative
dermatitis, toxic
epidermal necrolysis,
Stevens-Johnson
syndrome, severe
hepatic reactions (e.g.
 fulminant hepatitis,
hepatic necrosis or
failure).

DRUG NAME INDICATION, MECHANISM OF SIDE CONTRAINDICATIO NURSING

DOSAGES, ACTION EFFECTS/ADVERSE NS RESPONSIBILITIES
FREQUENCY, REACTION
ROUTE

ADMINISTRATION - Ferrous sulfate Gastrointestinal • Contraindicated in • GI upset may be

GENERIC NAME: works by providing System: Ferrous patients with related to dose.
P.O. the body with iron, sulfate is commonly hemosiderosis, • Enteric-coated
- Ferrous Sulfate • Between-meal which is an essential associated with primary products reduce GI
doses are preferable. component of gastrointestinal upset, hemochromatosis, upset
Drug hemoglobin, the including nausea, hemolytic anemia but also reduce
can be given with protein that carries vomiting, constipation, (unless patient also amount of iron
some foods, although oxygen in the blood. diarrhea, and has absorbed.
absorption may be By increasing the abdominal discomfort. iron deficiency Although this
decreased. body's supply of iron, These symptoms may anemia), peptic unabsorbed iron is
• Give tablets with ferrous sulfate can be alleviated by taking ulceration, harmless,
juice (preferably improve the the medication with ulcerative colitis, or it could mask melena.
orange juice) or water, symptoms of anemia, food or reducing the regional enteritis and • Monitor hemoglobin
but not with milk or such as fatigue, dose. in level, hematocrit,
antacids. weakness, and those receiving and reticulocyte count
• Don’t crush shortness of breath. Cardiovascular repeated blood during therapy.
extended-release System: Ferrous transfusions. • Look alike–sound
form. sulfate can cause • Use cautiously on alike: Don’t confuse
hypotension, long-term basis. different iron salts;
➤ Iron deficiency particularly if •H Overdose S&S: elemental content
administered too Abdominal pain, may vary.
Adults: One tablet rapidly. Patients coma,
P.O. b.i.d. to t.i.d. Or, should be monitored diminished tissue PATIENT TEACHING
5 ml (300 mg) P.O. for signs of perfusion, dyspnea, • Tell patient to take
t.i.d. between meals. hypotension, such as fever, tablets with juice
Children age 12 and dizziness, hyperglycemia, (preferably orange
older: 5 ml (300 mg) lightheadedness, or hypotension, lethargy, juice) or water, but not
P.O. t.i.d. between fainting. leukocytosis, with milk or antacids.
meals. metabolic acidosis, • Instruct patient not
Children age 4 and Respiratory System: nausea, to crush or chew
younger: 0.6 ml (75 Ferrous sulfate can tarry stools, vomiting, extended-release
mg cause allergic weak rapid pulse, form.
ferrous sulfate) P.O. reactions, including anuria, seizures, • Caution patient not
daily or as prescribed. difficulty breathing, pulmonary edema, to substitute one
wheezing, and shock, iron salt for another
swelling of the face or diffuse vascular because amounts of
throat. Patients who congestion, death. elemental iron vary.
experience these • Advise patient to
symptoms should seek report constipation
medical attention and
immediately. change in stool color
or consistency.
Skin and Allergic
Reactions: Ferrous
sulfate can cause skin
rash, itching, and
hives. Patients who
experience these
symptoms should stop
taking the medication
and seek medical
attention.

Central Nervous
System: Ferrous
sulfate may cause
headache and
dizziness in some
patients. Patients
should be advised to
report any unusual or
persistent symptoms.

Liver: Prolonged use

or overdose of ferrous
sulfate can lead to iron
toxicity, which can
cause liver damage.
Patients who
 experience abdominal
pain, vomiting,
diarrhea, or other
symptoms of iron
toxicity should seek
medical attention
immediately.

Teeth: Ferrous sulfate

can cause staining of
teeth if it comes into
contact with them.
Patients should be
instructed to rinse their
mouth after taking the
medication to avoid
this side effect.

DRUG NAME INDICATION, MECHANISM OF SIDE CONTRAINDICATIO NURSING

DOSAGES, ACTION EFFECTS/ADVERSE NS RESPONSIBILITIES
FREQUENCY, REACTION
ROUTE

- To treat -Interferes with CNS: Chills, fever, Hypersensitivity to -Use cefuroxime

GENERIC NAME: pharyngitis bacterial cell wall headache, seizures cefuroxime, other cautiously in patients
and tonsillitis synthesis by cephalosporins, or hypersensitive to
Cefuroxime axetil caused by inhibiting the final CV: Edema their componentsp penicillin because
cefuroxime sodium Streptococcus step in the cross-sensitivity has
pyogenes cross-linking of EENT: Hearing loss, occurred in about
BRAND NAME: peptidoglycan oral candidiasis 10% of such patients.
ORAL SUSPENSION strands.
Ceftin (CEFTIN) Peptidoglycan makes GI: Abdominal cramps, -Obtain culture and
Zinacef >Adults, adolescents, the cell membrane diarrhea, elevated liver sensitivity results, if
and children ages 3 rigid and protective. enzymes, hepatic possible and as
months to 12 years: Without it, bacterial failure, hepatomegaly, ordered, before giving
10 mg/kg daily every cells rupture and die. nausea, drug.
12 hr for 10 days. pseudomembranous
 colitis, vomiting -Give oral form with
Maximum: 500 mg food to decrease GI
daily. GU: Elevated BUN distress, as needed.
level, nephrotoxicity,
TABLETS (CEFTIN) renal failure, vaginal -Remember that oral
>Adults and candidiasis forms—tablets and
adolescents: suspension—aren’t
250 mg every 12 hr HEME: Eosinophilia, bioequivalent.
for 10 days. hemolytic anemia,
hypoprothrombinemia, -For I.V. use,
- To treat acute neutropenia, reconstitute using
otitis media thrombocytopenia, manufacturer’s
caused by unusual bleeding instructions according
Haemophilus to type of preparation
influenzae, MS: Arthralgia available. Solution
Moraxella ranges in color from
catarrhalis, RESP: Dyspnea light yellow to amber.
Streptococcus
pneumoniae, SKIN: Ecchymosis, -For I.M. use, add 3 or
or S. erythema, erythema 3.6 ml sterile water for
pyogenes multiforme, pruritus, injection to each
rash, 750-mg vial to yield
ORAL SUSPENSION Stevens–Johnson 220 mg/ml.
(CEFTIN) syndrome
>Children ages 3 L -Thaw frozen
months to 12 years: Other:Anaphylaxis; parenteral solution at
15 mg/kg every 12 hr injection-site edema, room temperature or
for 10 days. pain, and redness; under refrigeration
superinfection before administration;
Maximum: 1,000 mg make sure all ice
daily. crystals have melted.
Don’t force thawing by
TABLETS (CEFTIN) microwaving.
>Children under age
13 who can swallow -Store reconstituted
tablets: parenteral drug for up
250 mg every 12 hr to 24 hours at room
for 10 days. temperature or 96
hours in refrigerator.
- To treat (Thawed solutions
impetigo may be stable 24
 caused by hours at room
Staphylococcu temperature or 28
s aureus, or S. days if refrigerated.)
pyogenes Store reconstituted
oral suspension in
ORAL SUSPENSION refrigerator or at room
(CEFTIN) temperature up to 10
>Children ages 3 days.
months to 12 years:
15 mg/kg every 12 hr -Give I.V. injection
for 10 days. over 3 to 5 minutes
through tubing of a
Maximum: 1,000 mg flowing compatible I.V.
daily. fluid.

- To treat acute -Monitor I.V. site for

bacterial extravasation and
maxillary phlebitis.
sinusitis
caused by H. -Monitor BUN and
influenzae or serum creatinine
S. levels and fluid intake
pneumoniae and output to detect
signs of
ORAL SUSPENSION nephrotoxicity.
(CEFTIN)
>Children ages 3 -Monitor patients with
months to 12 years: renal impairment
15 mg/kg every 12 hr closely because they
for 10 days. may have greater
Maximum: 1,000 mg toxic reactions to
daily. cefuroxime.

TABLETS (CEFTIN) -Monitor patient for

>Adults, adolescents, allergic reactions
and children under continuing up to a few
age 13 who can days after therapy
swallow tablets: starts.
250 mg every 12 hr
for 10 days. -Patients with a
history of some form
 - To treat acute of allergy, especially
bacterial to drugs, are at
exacerbations increased risk for an
of chronic allergic reaction.
bronchitis
caused by H. -Assess bowel pattern
influenzae, daily; severe diarrhea
Haemophilus may indicate
parainfluenzae pseudomembranous
, or S. colitis. If it’s
pneumoniae suspected, stop drug,
(oral); lower as ordered, and
respiratory provide treatment as
tract infections prescribed.
including
pneumonia -Assess patient for
caused by E. arthralgia, bleeding,
coli, H. ecchymosis, and
influenzae, pharyngitis, which
Klebsiella may indicate a blood
species, S. dyscrasia.
aureus, S.
pneumoniae, -Monitor bleeding time
or S. pyrogens and PT, as ordered.
(parenteral);un Be prepared to
complicated administer vitamin K,
skin and if ordered, to treat
soft-tissue hypothrombinemia.
infections
caused by S. PATIENT TEACHING
aureus or S.
pyogenes(oral) -Instruct patient to
or shake oral suspension
Enterobacters well before measuring
pecies, E. coli, each dose and to use
Klebsiella a calibrated
species, S liquid-measuring
aureus, or S. device.
pyogenes
(parenteral) -Advise patient using
TABLETS (CEFTIN) single-dose pakets of
>Adults and oral suspension to
adolescents: empty contents of one
250 to 500 mg twice packet into a glass
daily (12 hr apart) for and add at least 10 ml
10 days. (2 tsp) of cold water;
apple, grape, or
I.V. INFUSION, I.V. orange juice; or
OR I.M. INJECTION lemonade.
(ZINACEF)
>Adults: -Tell him to stir well
750 mg every 8 hr for and consume entire
5 to 10 days. I.V. mixture at once.
injection given over at Inform patient that
least 3 to 5 min; I.V. buttermilk and yogurt
infusion given help maintain
intermittently over 15 intestinal flora and
to 60 min or as a can decrease diarrhea
continuous infusion. during therapy.
Instruct patient to
- To treat early report evidence of
Lyme disease blood dyscrasia to
caused by prescriber
Borrelia immediately.
burgdorferi
-Urge patient to report
TABLETS (CEFTIN) watery, bloody stools
>Adults and to prescriber
adolescents: immediately, even up
500 mg every 12 hr to 2 months after drug
for 20 days. therapy has ended.

- To treat
uncomplicated
UTI caused by
E. coli or
Klebsiella
pneumoniae

TABLETS (CEFTIN)
>Adult:
250 mg every 12 hr
for 7 to 10 days.

I.V. INFUSION, I.V.

OR I.M. INJECTION
>Adults:
750 mg every 8 hr for
5 to 10 days. I.V.
injection given over at
least 3 to 5 min; I.V.
infusion given
intermittently over 15
to 60 min or as a
continuous infusion.

- To treat
uncomplicated
gonorrhea
caused by
Neisseria
gonorrhoeae

TABLETS (CEFTIN)
>Adults:
1 g as a single dose.

I.M. INJECTION
(ZINACEF)
>Adults:
1.5 g as a single dose
divided equally and
injected into two
different sites; given
with oral probenecid 1
g.

- To treat
disseminated
gonococcal
infection and
uncomplicated
pneumonia
 caused by N.
gonorrhoeae

I.V. INFUSION, I.V.

OR I.M. INJECTION
(ZINACEF)
>Adults:
750 mg every 8 hr for
5 to 10 days. I.V.
injection given over at
least 3 to 5 min; I.V.
infusion given
intermittently over 15
to 60 min or as a
continuous infusion.

- To treat bone
and joint
infections
caused by S.
aureus

I.V. INFUSION, I.V.

OR I.M. INJECTION
(ZINACEF)
>Adults:
1.5 g every 8 hr. I.V.
injection given over at
least 3 to 5 min; I.V.
infusion given
intermittently over 15
to 60 min or as a
continuous infusion.

>Children over age 3

months:
150 mg/kg daily in
divided doses every 8
hr. I.V. injection given
over at least 3 to 5
min; I.V. infusion
given intermittently
over 15 to 60 min or
as a continuous
infusion.

Maximum: Adult
dose.

- To treat
bacterial
meningitis
caused by H.
influenzae,
Neisseria
meningtidis. S.
aureus, or S.
pneumoniae

I.V. INFUSION, I.V.

INJECTION
>Adult:
1.5 to 3 g every 8 hr.
I.V. injection given
over at least 3 to 5
min; I.V. infusion
given intermittently
over 15 to 60 min or
as a continuous
infusion.

>Children over age 3

months:
200 to 240
mg/kg/daily in divided
doses every 6 to 8 hr.
I.V. injection given
over at least 3 to 5
min; I.V. infusion
given intermittently
over 15 to 60 min or
as a continuous
infusion.

- To treat
moderate
infections
other than
those listed
above

I.V. INFUSION, I.V.

OR I.M. INJECTION
(ZINACEF)

>Adults:
750 mg every 8 hr for
5 to 10 days. I.V.
injection given over at
least 3 to 5 min; I.V.
infusion given
intermittently over 15
to 60 min or as a
continuous infusion.

I.V. INFUSION OR
INJECTION
(ZINACEF)

>Children over age 3

months: 50 mg/kg
daily in equally
divided doses every 6
to 8 hr. I.V. injection
given over 3 to 5 min;
I.V. infusion given
intermittently over 15
to 60 min or as a
continuous infusion.

- To treat severe
or complicated
infections
 other than
those listed
above

I.V. INFUSION OR
INJECTION
(ZINACEF)

>Adults:
1.5 g every 8 hr. I.V.
injection given over at
least 3 to 5 min; I.V.
infusion given
intermittently over 15
to 60 min or as a
continuous infusion.

>Children over age 3

months:
100 mg/kg daily in
equally divided doses
every 6 to 8 hr. I.V.
injection given over at
least 3 to 5 min; I.V.
infusion given
intermittently over 15
to 60 min or as a
continuous infusion.

- To treat
life-threatening
infections
other than
those listed
above

I.V. INFUSION OR
INJECTION
(ZINACEF)

>Adults:
1.5 g every 6 hr. I.V.
injection given over at
least 3 to 5 min; I.V.
infusion given
intermittently over 15
to 60 min or as a
continuous infusion.

- To provide
perioperative
prophylaxis

I.V. INJECTION
(ZINACEF)

>Adults:
1.5 g, given over at
least 3 to 5 min, 30 to
60 min before surgery
(at induction of
anesthesia for
open-heart surgery),
and then 0.75 g, given
over at least 3 to 5
min, every 8 hr for
prolonged procedures
(1.5 g, given over at
least 3 to 5 min, every
12 hr for total of 6 g
with open-heart
surgery).

DOSAGE
ADJUSTMENT

Parenteral dosage
reduced to 0.75 g
every 12 hr if
creatinine clearance is
10 to 20 ml/min or to
0.75 g every 24 hr if
creatinine clearance
less than 10 ml/min.